Hair Relaxer Lawsuit Guide
- Last Updated: November 19th, 2024
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Key takeaways:
- Plaintiffs allege that the chemicals in these products have caused serious health issues, including hormone-related cancers and reproductive problems.
- Recent studies have bolstered claims against hair relaxer products, linking their chemical components to various health risks.
- There is a call for stricter regulations and more transparent labeling on hair care products to ensure consumer safety.
Hair Relaxer Lawsuit Overview
On this page, we’ll discuss an overview of the Hair Relaxer Lawsuit, recent studies linking chemical hair treatments to various forms of cancer, potential Hair Relaxer Cancer Lawsuit settlement amounts and payouts, and much more.
Intro to the Hair Relaxer Lawsuits
Are you concerned about the potential health risks associated with hair relaxer products?
Recent legal developments have linked these common beauty items to serious conditions.
The use of these harmful chemicals leads to an increased risk of developing serious conditions including but not limited to uterine, ovarian, or breast cancer, endometriosis, uterine fibroids, or other injuries to the reproductive system.
Diving into more detail, let’s explore the list of common chemicals in hair relaxers that you should be aware of:
- Sodium Hydroxide (Lye): This is an extremely corrosive substance that can cause burns and harm to the skin and eyes.
- Calcium Hydroxide (No-Lye Relaxers): It’s less irritating but can still lead to scalp damage if not used properly.
- Guanidine Carbonate (No-Lye Relaxers): This chemical combines with calcium hydroxide to form Guanidine Hydroxide, which effectively straightens hair but can also cause scalp irritations.
- Formaldehyde: Known for its relation to cancer, this is a preservative often found in some hair smoothing and straightening products.
- Ammonium Thioglycolate (Thio Relaxers): While not as harsh as sodium hydroxide, it can cause allergic reactions and skin conditions like dermatitis.
- Parabens: These preservatives are known endocrine disruptors associated with breast cancer risks.
- Phthalates: Particularly Di(2-ethylhexyl) phthalate (DEHP), are usually found in hair relaxer products.
Table of Contents
Lawsuit Updates
-
November 2024 Updates:
November 12, 2024
The number of lawsuits involving hair relaxers continues to grow, with nearly 9,500 cases in federal courts and an additional 300 lawsuits filed in state courts across Illinois, Georgia, New York, Pennsylvania, and Delaware.
Most federal Hair Relaxer Lawsuits are consolidated under multidistrict litigation (MDL) in the Northern District of Illinois, overseen by Judge Mary Rowland.
Plaintiffs allege that toxic chemicals in popular products like Dark & Lovely, Just for Me, Optimum Care, and ORS Olive Oil have caused uterine cancer, endometrial cancer, ovarian cancer, and other injuries.
Federal Litigation Updates:
-
Status Conference: Judge Rowland recently addressed key issues, including motions to dismiss, deposition protocols, and the selection process for bellwether trials.
-
Discovery Phase: Evidence sharing for common claims is ongoing and expected to continue through late 2025.
-
Bellwether Trials: Early trials will test jury responses to evidence, which could help shape future settlement discussions.
-
Dismissals Without Prejudice: Claims involving injuries other than uterine, endometrial, or ovarian cancer were dismissed without prejudice, allowing plaintiffs to refile if one of these cancers develops.
State Court Developments:
-
Cook County, Illinois: A consolidation of 145 cases is being managed by Judge Kathy M. Flanagan. Five cases may be scheduled for trial following a November 26 hearing.
-
Other States: Georgia has 126 cases pending, followed by Pennsylvania (26), New York (4), and Delaware (1).
The litigation centers on uterine, endometrial, and ovarian cancers.
Studies reveal that women who regularly use hair relaxers face a 156% higher risk of uterine cancer.
Coordinated discovery and trials are designed to strengthen the foundation for future claims and settlement negotiations.
If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit.
Contact Tru Law for a free consultation or use the chatbot on this page for an instant case evaluation.
November 6, 2024
An increasing number of women are suing hair relaxer manufacturers, alleging that these products have caused severe health issues, including uterine, ovarian, and endometrial cancers.
In response, the U.S. District Judge presiding over these cases has appointed a Federal Magistrate Judge to oversee discovery disputes and ensure the claims progress smoothly.
Throughout the upcoming year, case management conferences will focus on major issues, potentially leading to trial dates.
The hair relaxer litigation, which began in 2022, originated from a study linking hair relaxer chemicals to a 156% increase in uterine cancer risk.
To date, over 9,500 lawsuits have been filed against popular brands like Dark & Lovely and Just for Me, alleging that these companies failed to warn consumers of the risks associated with endocrine-disrupting chemicals in their products.
Judge Rowland has established firm discovery deadlines, requiring written discovery by February 2025 and oral discovery by September 2025.
Magistrate Judge Beth W. Jantz has been assigned to handle any disputes during discovery, though she cannot alter the deadlines.
Monthly case management conferences will run from November 2024 to December 2025 to monitor discovery progress. Judge Rowland has also directed the parties to propose bellwether trial plans.
If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit.
Contact Tru Law for a free consultation or use the chatbot on this page for an instant case evaluation.
November 1, 2024
The Hair Relaxer lawsuit is ongoing.
The Hair Relaxer Lawsuit continues to grow as more individuals file claims alleging that hair relaxers and straighteners contain carcinogenic chemicals linked to cancer.
Plaintiffs argue that manufacturers failed to adequately warn consumers about these cancer risks, despite marketing these products heavily to women of color.
As of October, there were 8,393 active cases in the Hair Relaxer and Hair Straightener lawsuit.
By November, this number had surged to 9,488, reflecting an increase of 1,095 new filings.
Hair relaxers and straighteners often contain endocrine-disrupting chemicals associated with hormone-related cancers, presenting serious health risks for individuals using these products regularly over time.
If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit.
Contact Tru Law for a free consultation or use the chatbot on this page for an instant case evaluation.
-
-
October 2024 Updates:
October 21, 2024
The Hair Relaxer Lawsuit is ongoing.
As the number of Hair Relaxer Lawsuits continues to grow, the federal court overseeing the litigation has extended the discovery timeline into late 2025.
The current schedule includes written discovery to be completed by February 28, 2025, and oral discovery set to finish by September 30, 2025.
The litigation, centralized under the U.S. District Judge Mary Rowland in the Northern District of Illinois, addresses claims that popular hair relaxer products, such as Dark & Lovely and Just for Me, may cause uterine cancer, endometrial cancer, and ovarian cancer.
There are currently around 8,400 lawsuits pending in the Hair Relaxer MDL.
Plaintiffs allege that manufacturers failed to adequately warn consumers about the cancer risks associated with regular use of these chemical hair straighteners.
These lawsuits gained traction after a 2022 study revealed a 156% increased risk of uterine cancer for women who frequently used hair relaxers.
In November 2023, Judge Rowland ordered both parties to submit trial plans for selecting bellwether cases, which will help gauge how juries might respond to these claims.
While the parties have not yet agreed on the details of the trial process, the first cases are expected to go before juries in 2026 or later.
The outcome of these trials could significantly impact potential settlement negotiations, possibly resulting in settlements for women diagnosed with cancer after using these products.
If you or a loved one used chemical hair straighteners and developed cancer or other health problems, you may be eligible to file a Hair Relaxer Lawsuit.
Contact TruLaw’s Hair Relaxer Lawyers for a free consultation.
You can also use the chatbot on this page to find out if you qualify to file a Hair Relaxer Cancer Lawsuit instantly and connect with our Hair Relaxer Attorneys.
October 1, 2024
The Hair Relaxer Lawsuit is ongoing.
The Hair Straightener Cancer Lawsuit focuses on claims that chemicals used in hair relaxers and straighteners contain carcinogenic ingredients linked to an increased risk of certain cancers, including uterine and breast cancer.
Plaintiffs allege that manufacturers failed to warn consumers, particularly women of color, about the potential cancer risks associated with long-term use of these products.
In September, there were 8,489 cases filed in the Hair Relaxer MDL.
By October, the total number of cases had decreased to 8,393, reflecting a reduction of 96 filings.
This decrease may be due to the court’s decision not to allow certain diagnoses and medical monitoring cases to proceed within the litigation.
In August, plaintiff’s attorneys requested that the court dismiss, without prejudice, all cases with non-cancer injuries
Hair relaxers often contain chemicals like formaldehyde and endocrine-disrupting substances, which have been shown to affect hormone levels, potentially contributing to cancer development.
Studies indicate that frequent exposure to these chemicals increases the risk of hormone-related cancers, highlighting the significance of this lawsuit for the many women who have used these products over time.
If you or a loved one used chemical hair straighteners and developed cancer or uterine fibroids, you may be eligible to file a Hair Relaxer Lawsuit.
Contact TruLaw’s Hair Relaxer Lawyers for a free consultation.
-
September 2024 Updates:
September 19, 2024
The Hair Relaxer lawsuit is ongoing.
The Hair Relaxer multidistrict litigation (MDL), consolidating over 8,500 cases, has narrowed its focus to claims related to ovarian, uterine, and endometrial cancers.
In a rare move for mass tort cases, the plaintiff leadership has proactively sought to dismiss hundreds of unrelated claims to streamline the process.
Despite these developments, concerns remain that defendants are causing significant delays by withholding key documents necessary to complete general discovery.
These delays are slowing the progress of the litigation, leaving plaintiffs waiting for the resolution.
If you or a loved one has been affected, contact TruLaw for a free consultation.
You can also use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.
September 1, 2024
The Hair Relaxer Litigation has seen a significant rise in case filings, increasing from 7,946 in August to 8,489 in September.
Research indicates that certain chemicals in hair relaxers and straighteners, including formaldehyde and other endocrine-disrupting compounds, may elevate the risk of developing cancers such as uterine and breast cancer.
These chemicals can disrupt the body’s hormonal balance by mimicking or blocking natural hormones, which interferes with normal hormonal functions.
This disruption can lead to abnormal cell growth in hormone-sensitive tissues like the uterus and breasts, potentially resulting in cancerous tumors over time.
Formaldehyde, in particular, is a well-known carcinogen linked directly to cancer in humans.
You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.
Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.
-
August 2024 Updates:
August 28, 2024
Two U.S. Representatives, Ayanna Pressley from Massachusetts and Shontel Brown from Ohio, are urging the Food and Drug Administration (FDA) to explain the delay in proposing a ban on certain hair-straightening products that contain formaldehyde, a chemical linked to increased cancer risks.
They are joined by Rep. Nydia Velazquez of New York, who co-signed a letter to FDA Commissioner Robert Califf seeking clarity on the matter.
This letter follows the FDA’s 2023 announcement of a potential rule to ban these chemicals, which are predominantly used in products marketed to Black women.
The rule’s target date has been repeatedly postponed, shifting from April to July, and now to September, prompting the Congresswomen to demand an explanation for the delay.
Pressley highlighted that this delay could exacerbate health risks for communities of color, particularly Black women, who have long suffered from health issues related to hair straighteners.
This regulatory uncertainty coincides with the filing of thousands of lawsuits against beauty companies.
These lawsuits allege that the use of these products has increased the risk of uterine and ovarian cancers and caused infertility, and that manufacturers misrepresented the health risks, failing to warn consumers about the harmful chemicals adequately.
Studies from the National Institutes of Health in 2022 and Boston University in 2023 have both found significant links between the use of chemical hair straighteners and an elevated risk of uterine cancer.
You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.
Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.
August 1, 2024
The Hair Relaxer Lawsuit is ongoing.
The Hair Relaxer Cancer Lawsuit involves claims against manufacturers of chemical hair straighteners and relaxers.
Plaintiffs assert that these products cause cancers such as uterine and breast cancer due to harmful chemicals.
In July, there were 8,192 pending filings in the Hair Relaxer Cancer lawsuit, which decreased to 7,946 by August.
This reduction is likely due to certain injury claims no longer being accepted or the identification of duplicate cases.
The short form complaint, introduced this year, allows plaintiffs to file directly into the MDL, bypassing state courts.
This change may have led to some plaintiffs unintentionally creating duplicate cases.
Chemical hair straighteners and relaxers contain ingredients linked to an increased risk of cancers like uterine and breast cancer, as these chemicals can disrupt hormonal balances and contribute to the development of cancerous cells, leading many individuals to pursue legal action against the manufacturers.
You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.
Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.
-
July 2024 Updates:
July 19, 2024
The Hair Relaxer Lawsuit is ongoing.
The US Food and Drug Administration (FDA) has failed to implement its planned ban on formaldehyde in hair relaxer products, missing its own April deadline.
This delay comes amid thousands of lawsuits claiming that hair relaxer products containing formaldehyde have caused cancer and other serious health concerns.
These lawsuits allege that popular hair relaxer products have led to cancer, particularly targeting women who used these products.
Plaintiffs’ lawyers for those suffering from the negative health effects of hair relaxer products expressed disappointment at the FDA’s delay.
According to a statement from the FDA, the proposed rule to ban formaldehyde remains a high priority and is still in the rulemaking process.
The FDA cited the need for thorough risk assessments, literature reviews, and inter-agency approvals as reasons for the delay.
The FDA’s semiannual agenda of upcoming regulations, which includes the proposed formaldehyde ban, outlines these steps.
As the litigation progresses, plaintiffs and their attorneys hope for stricter regulations and greater accountability in the production and marketing of hair relaxer products.
You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.
Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.
July 5, 2024
The Hair Relaxer Lawsuit is ongoing.
Hair relaxer lawsuits highlight significant health risks, particularly affecting Black women.
Research by Dr. Tamarra James-Todd of Harvard reveals that chemicals in hair relaxers cause reproductive disorders and cancers.
These products contain endocrine-disrupting substances linked to early menstruation, uterine fibroids, preterm birth, infertility, and cancers.
Black women face a 28 percent higher breast cancer death rate than White women due to these issues.
Despite the known dangers, hair relaxers remain inadequately regulated by the FDA.
Many products contain banned substances like formaldehyde, and 84 percent of toxic ingredients are not listed on packaging, leaving consumers unprotected.
Lawsuits allege that manufacturers prioritize profits over safety, marketing dangerous products without proper warnings.
If you’ve suffered adverse health effects due to hair relaxer products, contact TruLaw today for a no-obligation consultation.
Our team will connect you with a dedicated Hair Relaxer Attorney within our network of legal partners to provide you with the strongest legal representation for your claim.
We are fully committed to securing the compensation you deserve.
July 1, 2024
The Hair Relaxer Lawsuit is ongoing.
The Hair Straightener lawsuit involves claims that certain hair straightening products contain harmful chemicals linked to cancer.
This lawsuit seeks to hold manufacturers accountable for the health risks associated with these products.
In June, there were 8,170 Hair Straightener lawsuit filings.
By July, this number increased to 8,192.
Hair straighteners contain toxic chemicals that can cause cancer by disrupting hormonal functions and damaging cellular DNA.
Prolonged exposure to these chemicals has led to serious health issues, prompting more individuals to join the Hair Straightener lawsuit.
The Hair Straightener lawsuit aims to hold manufacturers responsible for the harm caused by these dangerous products.
Affected individuals should consult a Hair Straightener lawsuit lawyer.
If you think your uterine cancer was caused by frequent exposure to hair-relaxing products, you deserve a chance to hold the manufacturer accountable for their negligence.
Contact TruLaw for a free, no-risk consultation to find out whether you have a case.
-
June 2024 Updates:
June 13, 2024
The Hair Relaxer Lawsuit is ongoing.
In February 2023, a federal judge consolidated thousands of individual lawsuits into a single multidistrict litigation addressing the harmful health effects linked to chemical hair relaxers.
The 2022 Sister Study, conducted by the National Institute of Environmental Health Sciences, found a clear association between regular use of hair straightening chemicals and an elevated risk of uterine cancer.
The lawsuits allege that manufacturers failed to ensure the safety of these products, which contain chemicals known to disrupt endocrine function.
These chemicals are implicated in serious reproductive health issues such as early puberty, infertility, and various cancers, disproportionately impacting Black women.
Despite these significant risks, regulation of these products in the United States remains minimal, especially compared to the more stringent measures in the European Union.
The creation of this multidistrict litigation is intended to streamline proceedings by combining cases with similar factual questions about the health risks associated with chemical hair relaxers.
If you or a loved one regularly used Hair Relaxers, chemical hair straighteners, or other related products and have been diagnosed with cancer or other health problems, call us today for a free consultation.
You can also use the chatbot on this page for an instant case evaluation.
June 3, 2024
The Hair Relaxer Lawsuit is ongoing.
The Hair Relaxer lawsuit alleges that chemical hair straightening products are linked to various cancer types.
The number of cases in the Hair Relaxer MDL has seen a decrease from 8,468 in May to 8,170 in June, a reduction of 298 cases.
This drop may reflect plaintiffs’ decisions to withdraw claims related to non-cancer injuries, thereby concentrating the litigation on cancer-specific allegations.
Studies suggest that chemicals in hair relaxers, absorbed through the scalp, may heighten the risk of cancers, including uterine and breast cancers.
Extended use of chemical hair relaxers, particularly over many years, is associated with an increased risk of uterine cancer, especially among postmenopausal women.
Women who frequently used these products (at least 5 times per year for over 15 years) exhibited a notably higher incidence of uterine cancer compared to less frequent users.
This link is even more pronounced among those who have used the products for 20 years or more, irrespective of usage frequency.
Individuals who have used hair relaxers and subsequently developed cancer should consider consulting with attorneys who specialize in Hair Relaxer cancer lawsuits.
If you or a loved one regularly used Hair Relaxers, chemical hair straighteners, or other related products and have been diagnosed with cancer or other health problems, call us today for a free consultation.
You can also use the chatbot on this page for an instant case evaluation.
-
May 2024 Updates:
May 14, 2024:
The Hair Relaxer Lawsuit is ongoing.
According to Case Management Order No. 11, plaintiffs are mandated to file their Short Form Complaints and Plaintiff Fact Sheets through a designated electronic database overseen by a third-party administrator.
This system centralizes the management of documents, ensuring all relevant parties have prompt access to essential records.
It also serves to monitor submission timelines and deadlines.
Participants in the lawsuit are required to upload their documents and maintain updated case details within the platform by specified deadlines.
It is crucial for plaintiffs to keep their contact information current within the system to receive automatic alerts when documents are due.
The court has established specific protocols for addressing letters and correcting any deficiencies in submissions.
All information entered into the platform is managed with high security, following strict guidelines for data access and modification.
If you or a loved one has developed cancer or other health problems after using Hair Relaxer products, you may be eligible to file a claim.
Contact us for a free consultation, or use the chatbot on this page to find out if you qualify for the Hair Straightener Lawsuit.
May 1, 2024:
The Hair Relaxer Lawsuit continues to progress.
The Food and Drug Administration (FDA) missed its own April 2024 deadline to release a proposal to ban formaldehyde in hair-straightening products.
Formaldehyde and similar chemicals in these products are linked to cancer risks.
Research, including a National Institutes of Health study of over 33,000 Black women, indicates a correlation between regular use of hair relaxers and increased uterine cancer risk.
Affected women have filed lawsuits against major cosmetic companies like L’Oreal and Revlon, though Revlon has previously stated there is no scientific support linking hair straighteners to cancer.
L’Oreal asserts its products do not contain formaldehyde yet supports the FDA’s proposed ban.
The Environmental Working Group has repeatedly petitioned the FDA to ban formaldehyde in hair products since 2011.
If you or a loved one regularly used Hair Relaxers, chemical hair straighteners, or other related products and have been diagnosed with cancer or other health problems, call us today for a free consultation.
You can also use the chatbot on this page for an instant case evaluation.
May 1, 2024:
The Hair Relaxer Multidistrict Litigation (MDL) continues to progress. According to the latest filings, 8,468 cases are currently pending.
In the past month, 81 new cases have been added to the MDL.
The lawsuits allege that the manufacturers of hair relaxer products failed to inform users about the risks associated with exposure to harmful chemicals present in these products, including a heightened risk of developing cancers such as uterine, ovarian, or breast cancer.
Individuals who developed cancer or other health issues after extended use of hair relaxers, hair straighteners, or similar products might be eligible to participate in the Hair Relaxer Lawsuit.
-
April 2024 Updates:
April 4, 2024:
The Hair Relaxer Lawsuit is currently active.
The Food and Drug Administration (FDA) is considering a proposal to ban certain chemicals found in hair relaxers due to emerging evidence that these chemicals may pose cancer risks.
This proposed ban would affect hair relaxers containing formaldehyde and similar substances, which have been linked to higher risks of respiratory tract cancers and myeloid leukemias.
These products are also known to include phthalates and other chemicals that disrupt hormonal functions, potentially contributing to cancer development.
In response to these findings, legal actions have already commenced, with lawsuits filed against various manufacturers of hair straighteners and relaxers, including the major company L’Oréal.
Our law firm is actively taking on new clients for the Hair Relaxer Lawsuit.
Contact us today for a complimentary consultation, or use the chatbot on this page to immediately check if you are eligible to join the Hair Relaxer Lawsuit
April 1, 2024:
The Hair Relaxer Lawsuit is actively progressing.
The recent filings to the Judicial Panel on Multidistrict Litigation (JPML) showing an increase in the number of lawsuits to 8,380 a significant rise from the 8,334 reported as of March 1st.
These lawsuits have been initiated by individuals who claim to have suffered adverse health effects, including cancer, after using hair relaxer products.
The litigation centers around allegations that manufacturers did not properly inform consumers about the potential health risks of chemicals in hair relaxers.
The primary concern is that certain chemicals may contribute to the development of various health conditions.
Plaintiffs are seeking compensation for damages resulting from the use of these products.
For those who have used hair relaxers and are now experiencing health issues, legal recourse may be an option worth exploring.
Eligibility for participation in the Hair Relaxer Lawsuit can be found through by using the chatbot feature on their website.
-
March 2024 Updates:
The lawsuit concerning hair relaxers continues to progress.
According to the latest filings by the Judicial Panel on Multidistrict Litigation (JPML), an additional 117 cases were incorporated into the Hair Relaxer Multidistrict Litigation (MDL) during February.
The JPML had previously reported a consolidation of 8,217 Hair Relaxer Lawsuits within the MDL as of February, with the numbers increasing to 8,334 by March 1st.
These lawsuits target several manufacturers, including L’Oreal, Softsheen-Carson (Optimum Relaxer), Dark & Lovely, Just For Me, Motions Hair, ORS Hair Care (Namaste Laboratories, LLC), and African Pride (Godrej Group), alleging that their hair relaxer products contain harmful chemicals that may significantly elevate the risk of various cancers.
Individuals who believe they or their loved ones have suffered health issues as a result of using these hair relaxers are encouraged to explore their legal options.
For immediate support and to find out if you qualify for the lawsuit, please utilize the chatbot feature available on this page.
The Hair Relaxer Lawsuit is ongoing.
-
December 2023 Updates:
December 28th, 2023 Hair Relaxer Lawsuit Update:
A recent study explored the link between the usage of chemical hair relaxers, which are commonly utilized by Black women in the United States, and the likelihood of developing uterine cancer.
The investigation tracked a cohort of 44,798 Black women from 1997 to 2019 and revealed that extensive use of hair relaxers (lasting 15 years or more, at a minimum of 5 times annually) was associated with a slightly elevated risk of uterine cancer.
To be more specific, among postmenopausal women, both moderate and heavy use of hair relaxers, as well as a duration of over 20 years of use regardless of frequency, demonstrated a heightened risk of uterine cancer.
There was no statistically significant connection found between the use of hair relaxers and the risk of uterine cancer among premenopausal women.
These findings imply that prolonged use of chemical hair relaxers could potentially be a risk factor for uterine cancer, especially among postmenopausal Black women.
-
November 2023 Updates:
November 15th, 2023 Hair Relaxer Lawsuit Update:
A federal judge, specifically U.S. District Judge Mary Rowland in Illinois, has permitted the majority of claims to proceed in a significant lawsuit alleging that chemical hair relaxer products produced by companies like L’Oreal USA and Revlon are the cause of cancer and other harm.
Judge Rowland rejected most of the companies’ contentions in their bid to dismiss the complaint within the multidistrict litigation, which encompasses over 8,000 lawsuits.
She determined that the plaintiffs had offered ample evidence to substantiate their accusations, which encompass claims of negligence, defective product design, and a failure to adequately caution customers about potential risks.
Of the 15 claims contained in the complaint, Rowland dismissed three entirely and a part of a fourth due to insufficient backing for the plaintiffs’ assertions of fraud.
These hair relaxer products, primarily marketed to women of color, include chemicals for permanently straightening textured hair.
Legal actions were instigated following a National Institutes of Health study published in October 2022, which found that women who used these products multiple times a year were more than twice as likely to develop uterine cancer.
While L’Oreal had previously expressed confidence in the safety of its products, and Revlon stated its disbelief in the existence of scientific evidence linking chemical hair straighteners or relaxers to cancer, smaller cosmetics companies, including some headquartered in India, are also implicated in the lawsuits.
One of the lead attorneys representing the consumers declared that the court’s decision supports their contention that the products and the instructions provided by the companies are responsible for causing cancer.
November 1st, 2023 Hair Relaxer Lawsuit Update:
The Plaintiff’s Steering Committee is pushing for an 11% set-aside from the total settlement or judgment in each case.
This split comprises 8% for work that benefits all parties involved and 3% for covering common benefit costs.
The motion also highlights unanimous support within the committee.
Nonetheless, these attorney fee percentages won’t impact victims’ compensation.
The primary focus remains on maximizing settlements for victims, which appears to be progressing effectively.
November, 2023 Hair Relaxer Lawsuit
In November 2023, the hair relaxer lawsuit saw significant developments.
The Plaintiff’s Leadership Committee (PLC) formally filed a status update with the Court, marking an essential step forward in this high-profile case.
Meanwhile, the number of pending lawsuits in the Illinois Multi-District Litigation (MDL) has surged to approximately 5,996.
As legal proceedings continue to intensify, we eagerly anticipate a ruling from the centralizing board on whether these individual cases will be condensed into a new class action lawsuit.
This litigation milestone could have substantial implications for all involved parties and create a precedent for future chemical hair product disputes.
-
October 2023 Updates:
October 2023, Hair Relaxer Lawsuit Update:
The Food and Drug Administration (FDA) is suggesting a prohibition on the inclusion of formaldehyde as an ingredient in hair relaxers, particularly in products designed for hair-smoothing and hair-straightening, which are commonly used by Black women.
Formaldehyde is a hazardous substance capable of causing irritation to the eyes, skin, lungs, and throat and has been associated with specific cancers, including myeloid leukemia.
The current FDA regulations do not mandate the pre-market approval of cosmetic products and their components, sparking concerns about the safety of these products.
Recent studies have illuminated the potential risks associated with chemical hair relaxers, revealing a heightened likelihood of uterine cancer among women who use such products.
Hair relaxers often contain endocrine disruptors that can disrupt the body’s hormone system, leading to a range of health issues, such as early puberty, fibroid tumors, infertility, and reduced fertility in women.
The FDA’s proposed prohibition follows concerns raised by congressional representatives and advocates regarding the safety of these products, particularly among Black women.
The intended date for implementing the ban is set for April.
Moreover, policies like the CROWN Act, which bars discrimination based on hair texture, have been gaining traction in numerous states to address concerns surrounding hair and societal norms.
October 1st, 2023, Hair Relaxer Lawsuit Update:
Judge Rowland recently issued Case Management Order No. 9 (CMO 9) to address the rapid increase in hair relaxer class action lawsuits.
This order establishes guidelines for the filing and handling of short-form complaints (SFC) by the numerous new plaintiffs participating in the MDL.
The surge in new chemical hair straightener lawsuits can be attributed to a bankruptcy judge’s order related to Revlon. This order mandates lawyers to file lawsuits in order to safeguard their claims against Revlon.
The first hair relaxer lawsuit was filed on October 21, 2022.
This lawsuit was significant because it was the first to legally challenge the safety of hair relaxers.
Key details of the lawsuit include:
- The lawsuit was filed against cosmetic companies.
- It was based on the scientific evidence linking hair relaxer usage and cancer risk.
- The lawsuit sought compensation for individuals who had developed cancer after using hair relaxers.
This lawsuit marked the beginning of legal action against manufacturers of hair relaxers.
Impact of the First Lawsuit
The first hair relaxer lawsuit had a significant impact.
It brought the issue of hair relaxer safety to the forefront and paved the way for further legal actions.
The impact of the lawsuit can be seen in several areas:
- It raised public awareness about the potential risks of using hair relaxers.
- It prompted further research into the safety of hair relaxers.
- It led to more lawsuits being filed against hair relaxer manufacturers.
-
September 2023 Updates:
September 18th, 2023, Hair Relaxer Lawsuit Update:
In the past three months, an additional 2,000 cases have joined the hair relaxer class action lawsuit.
At this rate, it is projected that the MDL will exceed 4,000 cases by the end of the year.
There is anticipation that this trend will persist and possibly even lead to the hair relaxer MDL becoming as large as the talcum powder MDL.
September 6th, 2023, Hair Relaxer Lawsuit Update:
Throughout the past month, several noteworthy developments have come forth.
During a recent status conference presided over by Judge Rowland, a firm deadline of August 30, 2023, has been established for the submission of a joint written status report concerning the dismissal motions related to McBride, the defendant.
There was also debate at the conference regarding Federal Rule 26(a)(1) and 30 (b)(6), which involve expert witnesses and company testimonials.
Both parties were arguing that the other’s witness selection and testimonial strategies did not align with one of the federal statutes.
Additionally, Dabur International, the parent company of Namaste Laboratories and a prominent defendant in the hair relaxer lawsuit, switched its legal counsel from Kirkland & Ellis LLC with new attorneys from Baker & McKenzie LLP.
Earlier this month, Dermoviva Skin Essentials Inc. was removed from the class action, however, the possibility of its reinstatement is still under consideration.
-
August 2023 Updates:
August 26th, 2023, Hair Relaxer Lawsuit Update:
Judge Rowland has slated a discovery hearing for October 2nd, 2023.
August 21st, 2023, Hair Relaxer Lawsuit Update:
A woman from Brooklyn, Minnesota, has become a recent addition to the hair relaxer class action MDL.
The lawsuit alleges that between 1985 and 2011, the plaintiff used three chemical hair relaxer products: ORS Olive Oil, Just for Me, and S&B Botanicals.
In 2019, the plaintiff was diagnosed with endometrial cancer, which she attributes to the use of these hair relaxer products.
August 18th, 2023, Hair Relaxer Lawsuit Update:
New hair relaxer cancer lawsuits can now be submitted directly to the class action MDL using an approved Short Form Complaint, as authorized by Judge Rowland.
This new process is expected to streamline and expedite the filing of such lawsuits, potentially resulting in a higher number of new filings in the MDL.
30 new cases have been added to the hair relaxer class action MDL over the previous month, bringing the total number of pending cases to 275.
August 1st, 2023, Hair Relaxer Lawsuit Update:
New hair relaxer cancer lawsuits can now be submitted directly to the class action MDL using an approved Short Form Complaint, as authorized by Judge Rowland.
This new process is expected to streamline and expedite the filing of such lawsuits, potentially resulting in a higher number of new filings in the MDL.
-
July 2023 Updates:
July 18th 2023, Hair Relaxer Lawsuit Update:
The MDL saw a significant increase in hair relaxer cancer lawsuits last month, with 87 new cases added, marking the highest monthly total since the start of the MDL.
This surge continues a steady upward trend in new case filings observed over the past four months.
In February, there were only 21 pending cases in the MDL, but currently, there are 236 pending cases.
July 5th, 2023, Hair Relaxer Lawsuit Update:
Revlon provided an update on their ongoing bankruptcy proceedings and responded to the plaintiffs’ status report, submitted on June 30, 2023, before the MDL judge.
Despite being in bankruptcy, the significance of Revlon’s case lies in its possession of a substantial insurance policy to cover hair relaxer cancer lawsuits.
The company is responsible for various hair relaxer brands, including Crème of Nature, African Pride, French Perm, Fabulaxer, Revlon Professional, Revlon Realistic, Herbarich, and All Ways Natural Relaxer.
-
June 2023 Updates:
June 8th, 2023, Hair Relaxer Lawsuit Update:
Attorneys representing victims in federal hair relaxer lawsuits are urging the Court to reject a proposal by the product manufacturers to divide the discovery process, citing concerns about potential lengthy delays in the litigation.
Manufacturers of hair relaxer products, in response to mounting lawsuits, have requested the court to bifurcate discovery.
This would limit discovery to general causation information on the link between hair relaxers and cancer while staying all other discovery related to manufacturers’ liability, awareness of risks, and extent of damages.
June 5th, 2023, Hair Relaxer Lawsuit Update:
In a brief submitted on June 5th, plaintiffs underscored bifurcation’s potential to cause substantial delays in the litigation process, escalate costs significantly, and its track record of being “incredibly inefficient” in achieving a resolution or settlement.
Hair Relaxers and Links to Cancer
Numerous studies and mounting lawsuits have highlighted the potential link between the use of hair relaxers and an increased risk of developing certain types of cancers, including uterine and ovarian cancer.
Chemical Hair Relaxers: Uterine Cancer
Scientific research suggests a correlation between certain chemicals in hair relaxers and an increased risk of uterine cancer.
Lye-based relaxers, as well as no-lye alternatives that contain endocrine-disrupting compounds, pose potential health hazards.
These disruptive substances can interfere with the body’s hormonal system leading to significant adverse health effects such as uterine cancer.
Regular use of these products is particularly concerning for African American women who are disproportionately represented in related statistics.
The link between chemical hair straighteners or relaxers and higher rates of this type of malignancy adds another layer to the ongoing investigations into personal care product safety concerns.
Mounting evidence has resulted in numerous lawsuits being filed against cosmetic companies offering these suspect hair-relaxing products.
Hair Relaxer Can Cause Ovarian Cancer
Scientific research links consistent use of lye-based hair relaxers to a heightened risk of ovarian cancer.
Such products contain powerful alkaline chemicals, like sodium hydroxide.
Their main purpose is to permanently break down the protein structure in curly hair, providing a smoother texture. However, these agents aren’t exclusive to lye-based treatments.
No-lye relaxers also carry harmful ingredients that pose serious health threats.
For instance, calcium hydroxide and guanidine carbonate merge to form guanidine hydroxide once applied – an alkaline as corrosive as those found in lye variants.
These substances penetrate deep into the scalp with each application, potentially tying them to various complications beyond hair damage like scalp burns and irreversible alopecia — ovarian cancer being one severe implication regularly investigated by experts across health and cosmetic fields today.
Thousands of black women are coming forward with claims that prolonged use of these chemical hair products has directly contributed to their cancer diagnoses.
The specific chemicals in hair relaxers, such as endocrine-disrupting compounds, are now under scrutiny for their significant adverse health effects.
Stay informed about this critical issue impacting countless individuals who’ve trusted these products as part of their beauty routines.
Minorities Affected at Higher Rate
Rates of these types of cancers are significantly higher among black women and other minority groups.
These disturbing revelations have sparked outrage and concern amongst users worldwide, pushing many into legal battles.
There’s an ever-growing body of evidence suggesting lye-based relaxers significantly increase cancer risk, while even “no-lye” options contain harmful substances associated with detrimental health outcomes.
African American and Latina women have filed lawsuits alleging that regular application of these straightening agents has directly contributed to their diagnosis of ovarian or uterine cancer.
Latest News on the Hair Relaxer Lawsuit
The latest news on the hair relaxer lawsuit reveals that there has been a surge in new lawsuits against hair relaxer companies due to the discovery of new research linking the use of these products to uterine cancer.
Major beauty companies like L’Oreal and Revlon are under scrutiny and their cases are allowed to proceed as per a recent ruling by a U.S federal judge.
Here are some key updates on the hair relaxer lawsuit:
- A surge in new lawsuits: This is due to the discovery of new evidence suggesting that the chemicals in hair relaxers can cause uterine cancer.
- Major beauty companies under scrutiny: Lawsuits against L’Oreal and Revlon are proceeding, as ruled by a U.S. federal judge.
- No class action lawsuit: Currently, there is no class action lawsuit for hair relaxers.
Surge in New Lawsuits
New scientific research has found a link between the chemicals in hair relaxers and uterine cancer.
This has led to an explosion of new lawsuits against hair relaxer companies.
Women who have used these products for long periods are at an increased risk of developing uterine cancer.
Major findings from the research include:
- The chemicals in hair relaxers can cause uterine cancer.
- Long-term use of these products increases the risk of developing this type of cancer.
- The new research has led to a surge in lawsuits against hair relaxer companies.
This new evidence has fueled a wave of legal action against manufacturers of hair relaxers.
Major Beauty Companies Under Scrutiny
Lawsuits against major beauty companies like L’Oreal and Revlon are proceeding.
A U.S. federal judge has allowed the majority of claims in these cases to move forward.
The major developments in these cases include:
- A U.S. federal judge has allowed the majority of claims to move forward.
- These lawsuits claim that chemical hair relaxer products sold by these companies can cause uterine cancer.
- The decision by the judge has paved the way for further litigation against these companies.
Major corporations are facing increased legal challenges due to the harmful effects of their hair relaxer products.
One significant update was the FDA’s proposal in October 2023 to ban specific ingredients found in hair relaxers, which has only amplified the existing lawsuits against manufacturers.
This shift represents mounting pressure on manufacturers who have allegedly been aware of – yet failed to disclose – potential health risks caused by phthalates present in their hair relaxers.
Recent lawsuit filings also indicate that individuals are no longer just seeking compensation for medical costs associated with treating cancers linked with these products.
In addition, individuals are now demanding punitive damages for losses suffered due to misrepresentation and negligence on the part of these large corporations.
As more developments unfold each day, we must stay vigilant about understanding our rights and options when it comes to filing a claim regarding any injury potentially caused by hair relaxers or similar treatments.
Hair Relaxer Lawsuits: Past and Present
This section includes notable cases such as the Hair Relaxer Cancer Lawsuits that stirred up public awareness of potential risks posed by these cosmetic products.
We also shed light on the legal aspects concerning these suits, like what constitutes the statute of limitations for filing a hair relaxer lawsuit.
Hair Relaxer Cancer Lawsuits
Reports of hair relaxer cancer lawsuits have been surging, with victims demanding justice.
These are some of the recent notable cases:
- Ongoing hair relaxer cancer lawsuits highlight the potential risks associated with using these products, with many consumers now seeking legal action.
- Product liability lawsuits often involve individuals who have used hair relaxer treatments for extended periods and subsequently get diagnosed with cancer.
- A significant lawsuit in 2022 alleged that hair straightening products caused uterine cancer, leading to an increase in similar lawsuits across the country.
- Claims in these suits often suggest that chemical hair relaxers may contribute to various health problems, including ovarian and uterine cancers.
- L’oreal USA, one of the major hair relaxer manufacturers, is frequently cited as a defendant in these cases due to its popularity and widespread use.
Statute of Limitations: Hair Relaxer Cancer Cases
Every state establishes its own statute of limitations for hair relaxer lawsuits.
This legal time limit can vary significantly from one jurisdiction to another, typically ranging anywhere between 2 to 6 years.
The clock usually starts the day a victim discovers or should have discovered their injury or illness, such as cancer, which they believe resulted from exposure to harmful chemicals in hair relaxer products.
Understanding the specific statute of limitations in your state is crucial because if you attempt to file a claim after this period has expired, courts will almost certainly dismiss it without reviewing the merits of your case.
Therefore, timely action is essential when considering a lawsuit against hair relaxer manufacturers.
Contact Us About a Hair Relaxer Cancer Lawsuit
If you’ve suffered adverse health effects due to hair relaxer products, contact TruLaw today for a no-obligation consultation.
Our team will connect you with a dedicated Hair Relaxer Attorney within our network of legal partners to provide you with the strongest legal representation for your claim.
We are fully committed to securing the compensation you deserve.
Hair Relaxer Settlement and Payout Amounts
Hair relaxer lawsuits have seen substantial payouts depending on the severity of the disease, the impact on the individual, and other influencing factors.
The settlement amounts can vary greatly, but it’s estimated that they can range anywhere from $100,000 to $1,500,000.
Here’s an outline of potential payout amounts:
- Minor Side Effects (Hair loss, scalp irritation): $100,000 – $200,000
- Major Side Effects (Hormonal problems, skin problems): $200,000 – $500,000
- Cancer (Breast, Uterine, Ovarian): $500,000 – $1,500,000
In November 2023, the Plaintiff’s Leadership Committee (PLC) formally filed a status update with the Court, marking an essential step forward in this high-profile case.
Meanwhile, the number of pending lawsuits in the Illinois Multi-District Litigation (MDL) has surged to approximately 5,996.
As legal proceedings continue to intensify, we eagerly anticipate a ruling from the centralizing board on whether these individual cases will be condensed into a new class action lawsuit.
This litigation milestone could have substantial implications for all involved parties and create a precedent for future chemical hair product disputes.
Advancements & Developments in the Hair Relaxer Litigation
Explore the major strides within the hair relaxer litigation, including pivotal court outcomes, a growing number of cases, and the recent entry of new law firms joining this critical legal battle.
We’ll discuss how these developments impact potential settlements for victims who’ve suffered from harmful effects linked to hair relaxers.
Revlon Bankruptcy
Revlon Inc. recently declared Chapter 11 bankruptcy while contending with a flood of new lawsuits.
These legal battles surround allegations that the company’s hair relaxer products have been linked to cancer in thousands of consumers.
Despite transferring ownership to creditors and eliminating shareholders as part of their April 2023 emergence from bankruptcy, Revlon holds continued liability for these claims.
The company does maintain a substantial insurance policy intended to cover litigation costs related to these ongoing hair relaxer lawsuits, even amid its financial restructuring process.
New MDL Management Order
A fresh Multidistrict Litigation (MDL) Management Order has been enacted, making waves in the realm of hair relaxer litigation.
Specifically, this directive facilitates the filing of new hair relaxer cancer lawsuits straight into the class action MDL.
Moreover, this means that plaintiffs alleging injury from these chemical products can now utilize an authorized Short Form Complaint.
This form expedites the submission process within the MDL.
The pivotal MDL consolidates all issues regarding liability for hair relaxer product cases across federal courts.
It also provides a centralized location – Chicago’s Northern District of Illinois – for these proceedings to take place under unified management.
Moreover, it offers direction for direct filings related to ongoing cases against manufacturers and distributors alleged to make or sell harmful hair chemicals.
Hair Relaxer MDL Adds 2,000 New Cases in 3 Months
A significant surge in the number of lawsuits related to hair relaxers has been observed recently.
Specifically, the Multidistrict Litigation (MDL) concerning these cases added an astounding 2,000 new cases within a span of just three months.
The MDL is now expected to exceed more than 4,000 cases in total due to this rapid increase in claims regarding carcinogenic harm associated with chemical hair products.
This large influx emphasizes the serious concerns being raised about the safety and health implications of using such beauty products regularly.
How to File a Hair Relaxer Claim
Filing a hair relaxer claim involves several crucial steps.
These steps are designed to help individuals who’ve used chemical hair products protect their rights and potentially receive financial compensation for any harm caused by these products:
- Consult with a Lawyer: Engage in dialogue with an attorney who specializes in hair relaxer lawsuits. They can guide you through the process and evaluate your case’s strengths.
- Collect Evidence: Compile all documents related to your use of hair relaxers, including purchase receipts, medical records documenting health issues, or photographic evidence showing changes in your health after using these products.
- File a Short-Form Complaint: Following the judge’s order on August 3, 2023, new hair relaxer cancer lawsuits can be filed directly in the class action MDL using the approved Short Form Complaint.
- Stay Informed About Proceedings: Keep tabs on ongoing developments in the class action lawsuit, particularly concerning potential hair relaxer settlements or verdicts that may influence your claim.
- Be Prepared for Legal Proceedings: If your case proceeds to trial or settlement talks, make sure to cooperate fully with your attorney and be ready to testify if needed.
MDL Panel Meets to Discuss Hair Relaxer Lawsuits
A significant development in the hair relaxer litigation landscape took place as the MDL (Multi-District Litigation) panel met to review current and prospective lawsuits.
Tasked with overseeing and streamlining complex litigations related to hair relaxer products, the panel’s meeting is a pivotal event for all involved parties.
They analyzed case details, discussed potential resolutions, and considered implications for future claims.
The meeting helped shape the direction and strategies of new cases emerging in this rapidly evolving legal field.
Essential decisions made at these meetings can affect eligibility rules, compensation amounts, or even influence how quickly settlements are reached.
This update marks an important step forward in holding manufacturers accountable for the alleged health ramifications of chemical hair products.
Contact Us About a Hair Relaxer Cancer Lawsuit
If you’ve suffered adverse health effects due to hair relaxer products, contact TruLaw today for a no-obligation consultation.
Our team will connect you with a dedicated Hair Relaxer Attorney within our network of legal partners to provide you with the strongest legal representation for your claim.
We are fully committed to securing the compensation you deserve.
Hair Relaxer Lawsuit: Updates & Conclusion
As of the latest updates in November 2023, the hair relaxer lawsuits are progressing with most plaintiff’s claims being allowed to proceed.
The multidistrict litigation (MDL) concerning these lawsuits is expected to grow as new cases are added.
Here are the key updates about the Hair Relaxer Lawsuit:
- Denial of Motion to Dismiss: The motion to dismiss the lawsuits was denied, allowing most of the plaintiffs’ claims to move forward.
- Potential Link between Hair Relaxers and Cancer: A recent study has confirmed a link between hair relaxers and cancer, further strengthening the plaintiffs’ cases.
- Consolidation into a New MDL: All hair relaxer cancer lawsuits have been consolidated into a new MDL class action litigation in the Northern District of Illinois.
Denial of Motion to Dismiss
The motion to dismiss the hair relaxer lawsuits was denied, meaning that the majority of the plaintiff’s claims were allowed to proceed.
This is a significant step in the legal process, as it means that the court has found that the plaintiffs have sufficiently stated a claim for which relief can be granted.
Key points to note about the denial of a motion to dismiss:
- This development indicates that the court has found merit in the plaintiffs’ claims.
- It also means that the defendants will need to prepare a defense to these claims.
- The denial of the motion to dismiss is not a determination of guilt or innocence, but rather an indication that the plaintiffs’ claims are legally sufficient to move forward to the next stage of the legal process.
Hair Relaxers and Cancer: Potential Link
A recent study has confirmed a link between hair relaxers and cancer, further strengthening the plaintiffs’ cases.
This scientific evidence is crucial in substantiating the plaintiffs’ claims and could potentially influence the outcome of the lawsuit.
Key points to note about the link between hair relaxers and cancer:
- The study provides scientific evidence supporting the plaintiffs’ claims that hair relaxers can cause cancer.
- This development could significantly impact the defendants’ defense strategy and potentially influence the outcome of the lawsuit.
- The confirmation of the link between hair relaxers and cancer highlights the importance of product safety and consumer protection.
Consolidation into a New MDL
All hair relaxer cancer lawsuits have been consolidated into new MDL class action litigation in the Northern District of Illinois.
This consolidation is expected to streamline the legal process and ensure consistency in the handling of these cases.
Key points to note about the consolidation into a new MDL:
- The consolidation is expected to streamline the legal process by allowing similar lawsuits to be handled collectively.
- This development ensures consistency in the handling of these cases and prevents contradictory verdicts.
- The consolidation into an MDL also allows for more efficient sharing of resources among the plaintiffs’ attorneys.
Concluding Updates on Hair Relaxer Lawsuits
In summary, the hair relaxer lawsuits are progressing, with most plaintiffs’ claims being allowed to proceed.
If you’ve suffered adverse health effects due to hair relaxer products, contact TruLaw today for a no-obligation consultation.
Our team will connect you with a dedicated Hair Relaxer Attorney within our network of legal partners to provide you with the strongest legal representation for your claim.
We are fully committed to securing the compensation you deserve.
Frequently Asked Questions
-
What is the latest update in the Hair Relaxer Lawsuit?
The latest update in the Hair Relaxer Lawsuit is that Judge Mary Rowland has denied the defendant’s motion to dismiss most claims in the class action, allowing the negligence, strict liability, and failure to warn claims to proceed.
Here are the key takeaways regarding the latest development in the Hair Relaxer Lawsuit:
- Judge Mary Rowland’s decision: The judge has allowed most claims to advance while dismissing some, such as fraud-based claims.
- Consolidation of Lawsuits: All hair relaxer cancer lawsuits have been consolidated into a new MDL in the Northern District of Illinois.
- The FDA and Hair Relaxer Products: The FDA has proposed a ban on formaldehyde in hair relaxer products, indicating the potential risks associated with these products.
If you’ve suffered adverse health effects due to hair relaxer products, contact TruLaw today for a no-obligation consultation.
Our team will connect you with a dedicated Hair Relaxer Attorney within our network of legal partners to provide you with the strongest legal representation for your claim.
We are fully committed to securing the compensation you deserve.
-
What is a hair relaxer lawsuit?
A hair relaxer lawsuit is a legal action taken against manufacturers of hair relaxer products.
Here is a detailed look at some key aspects of hair relaxer lawsuits:
- Causes of Hair Relaxer Lawsuits: Plaintiffs allege that hair relaxer products contain harmful chemicals that cause health problems, such as cancer and fertility issues.
- Consolidation into Class Action MDL: This allows multiple cases from different federal courts to be centralized, simplifying the legal process.
- Potential Settlement Value: The potential settlement value for these lawsuits is uncertain.
-
How are new hair relaxer lawsuits related to uterine cancer?
Nearly 60 lawsuits have been filed against L’Oreal, alleging that the brand’s hair relaxers have caused cancer.
These hair relaxers typically contain multiple chemicals, a number of which are identified as endocrine disruptors.
These chemicals often found in hair relaxers are:
- Preservatives such as parabens
- Stabilizing agents like formaldehyde
- Plasticizers including phthalates
- Various other chemical compounds
These substances can mimic or interfere with the body’s hormones, potentially leading to an increased risk of hormone-related cancers such as uterine cancer.
-
Who files these federal hair relaxers lawsuits?
Federal lawsuits against manufacturers of hair relaxers, such as those filed against L’Oreal, are typically initiated by individuals who have allegedly suffered adverse health effects, such as cancer, purportedly due to the use of these products.
These claimants often include:
- Consumers: Individuals who have used hair relaxers and subsequently developed health issues like uterine cancer.
- Legal Guardians or Family Members: In cases where the affected individual is unable to file a lawsuit themselves, their legal guardians or family members may file the lawsuit on their behalf.
- Estates of Deceased Individuals: If the use of hair relaxers is believed to have contributed to an individual’s death, the estate of the deceased can file a lawsuit.
-
When was the first Hair Relaxer Lawsuit was registered?
The first hair relaxer lawsuit was registered in October 2022.
This initial lawsuit was filed by a woman from Georgia, Keaira G., who claimed that hair relaxers caused her uterine fibroids.
She reported that her first exposure to hair relaxers occurred in 1994 when she was six years old, either at hair salons or through the use of at-home kits.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
You can learn more about the Hair Relaxer Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
